Like_老虎社区_美港股上老虎

brijeshnair
2021-10-15

Generic drug maker Teligent files for bankruptcy protection, explores sale of the company

South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy pr

Generic drug maker Teligent files for bankruptcy protection, explores sale of the company

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":824043682,"tweetId":"824043682","gmtCreate":1634264655689,"gmtModify":1634274404389,"author":{"id":4092798624667290,"authorId":4092798624667290,"authorIdStr":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like</p></body></html>","htmlText":"<html><head></head><body><p>Like</p></body></html>","text":"Like","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/824043682","repostId":1182032876,"repostType":4,"repost":{"id":"1182032876","pubTimestamp":1634263136,"share":"https://www.laohu8.com/m/news/1182032876?lang=&edition=full","pubTime":"2021-10-15 09:58","market":"us","language":"en","title":"Generic drug maker Teligent files for bankruptcy protection, explores sale of the company","url":"https://stock-news.laohu8.com/highlight/detail?id=1182032876","media":"THE BUSINESS JOURNALS","summary":"South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy pr","content":"<p>South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets.</p>\n<p>Teligent Inc. of Buena in Atlantic County also said it is arranging for $12 million debtor-in-possession financing from its senior secured lenders.</p>\n<p>The company also announced that CEO&nbsp;Tim SawyerandPhilip Yachmetz, Teligent's chief legal officer and executive vice president, resigned effective Oct. 8.</p>\n<p>Shares of the company are down 47% in pre-market trading Thursday to 18 cents.</p>\n<p>Teligent (NASDAQ: TLGT) filed for Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The filing does not yet list specific assets and liabilities. It did note AmerisourceBergen (NYSE: ABC) is owed $8.3 million, making the Conshohocken-based wholesale pharmaceutical distributor Teligent's largest unsecured creditor.</p>\n<p>Teligent began marketing itself ahead of the Chapter 11 filing to determine the level of interest in the company and is in ongoing discussions with several interested parties, the company said. Teligent expects to finalize a sale of the entire business, or its core assets, by early 2022.</p>\n<p>\"The entire Teligent team has worked diligently over the past year to address market trends, our debt structure, and operational hurdles that have challenged our business,\" saidJohn Celentano, board chairman of Teligen, in a statement. \"While this is not the outcome we envisioned, we are confident that Teligent's business includes a strong portfolio of specialty generic prescription assets and believe a sale is the best opportunity to maximize value.\"</p>\n<p>Last year, Teligent generated revenue of $45.3 million and a net loss of $122 million. In 2019, it had sales of nearly $65.9 million and a loss of $25.1 million.</p>\n<p>Teligent has spent the past two years engaged in remediation efforts for its South Jersey manufacturing plant after the Food and Drug Administration cited deficiencies at the plant in a warning letter issued to the company in November 2019. Teligent halted its production of certain undisclosed products while it continues to work to address the FDA's concerns.</p>\n<p>The company's use of its newly constructed sterile injectable manufacturing plant has also been delayed because of the uncertainty regarding the timing the&nbsp;FDA's inspection of the site.</p>\n<p>Last month, Teligent issued a voluntary recall for a Lidocaine product because of a potency issue. The company has not received any reports of adverse events related to this recall.</p>\n<p>In connection with the bankruptcy filing, Teligent appointed&nbsp;Vladimir Kasparov, managing director at Portage Point Partners, as chief restructuring officer.</p>\n<p>Founded in 1977, Teligent markets more than three dozen generic topical pharmaceutical products formulated as ointments, creams, lotions and gels. The company has over 140 employees, including 114 in Canada.</p>\n<p>The company's Canadian affiliate, Teligent Canada, will be pursuing an out-of-court sale process.</p>","source":"lsy1633760424806","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Generic drug maker Teligent files for bankruptcy protection, explores sale of the company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGeneric drug maker Teligent files for bankruptcy protection, explores sale of the company\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-15 09:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bizjournals.com/philadelphia/news/2021/10/14/teligent-buena-south-jersey-chapter-11-bankruptcy.html?ana=yahoo><strong>THE BUSINESS JOURNALS</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets.\nTeligent Inc. of ...</p>\n\n<a href=\"https://www.bizjournals.com/philadelphia/news/2021/10/14/teligent-buena-south-jersey-chapter-11-bankruptcy.html?ana=yahoo\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.bizjournals.com/philadelphia/news/2021/10/14/teligent-buena-south-jersey-chapter-11-bankruptcy.html?ana=yahoo","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182032876","content_text":"South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets.\nTeligent Inc. of Buena in Atlantic County also said it is arranging for $12 million debtor-in-possession financing from its senior secured lenders.\nThe company also announced that CEO Tim SawyerandPhilip Yachmetz, Teligent's chief legal officer and executive vice president, resigned effective Oct. 8.\nShares of the company are down 47% in pre-market trading Thursday to 18 cents.\nTeligent (NASDAQ: TLGT) filed for Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The filing does not yet list specific assets and liabilities. It did note AmerisourceBergen (NYSE: ABC) is owed $8.3 million, making the Conshohocken-based wholesale pharmaceutical distributor Teligent's largest unsecured creditor.\nTeligent began marketing itself ahead of the Chapter 11 filing to determine the level of interest in the company and is in ongoing discussions with several interested parties, the company said. Teligent expects to finalize a sale of the entire business, or its core assets, by early 2022.\n\"The entire Teligent team has worked diligently over the past year to address market trends, our debt structure, and operational hurdles that have challenged our business,\" saidJohn Celentano, board chairman of Teligen, in a statement. \"While this is not the outcome we envisioned, we are confident that Teligent's business includes a strong portfolio of specialty generic prescription assets and believe a sale is the best opportunity to maximize value.\"\nLast year, Teligent generated revenue of $45.3 million and a net loss of $122 million. In 2019, it had sales of nearly $65.9 million and a loss of $25.1 million.\nTeligent has spent the past two years engaged in remediation efforts for its South Jersey manufacturing plant after the Food and Drug Administration cited deficiencies at the plant in a warning letter issued to the company in November 2019. Teligent halted its production of certain undisclosed products while it continues to work to address the FDA's concerns.\nThe company's use of its newly constructed sterile injectable manufacturing plant has also been delayed because of the uncertainty regarding the timing the FDA's inspection of the site.\nLast month, Teligent issued a voluntary recall for a Lidocaine product because of a potency issue. The company has not received any reports of adverse events related to this recall.\nIn connection with the bankruptcy filing, Teligent appointed Vladimir Kasparov, managing director at Portage Point Partners, as chief restructuring officer.\nFounded in 1977, Teligent markets more than three dozen generic topical pharmaceutical products formulated as ointments, creams, lotions and gels. The company has over 140 employees, including 114 in Canada.\nThe company's Canadian affiliate, Teligent Canada, will be pursuing an out-of-court sale process.","news_type":1},"isVote":1,"tweetType":1,"viewCount":597,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}